Prevention of perinatal hepatitis B virus transmission

Journal of the Pediatric Infectious Diseases Society

Volumn 3, Issue SUPPL1, 2014, Pages

  Nelson, Noele P ^a   Jamieson, Denise J ^b   Murphy, Trudy V ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Antivirals; Hepatitis B; Hepatitis B immune globulin; Hepatitis B vaccine; Hepatitis B virus; Mother to child transmission; Perinatal transmission

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS E ANTIGEN; LAMIVUDINE; PEGINTERFERON; TELBIVUDINE; TENOFOVIR DISOPROXIL; VIRUS DNA;

ARTICLE; BATH; CLINICAL FEATURE; DELIVERY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; INTRAPARTUM CARE; MATERNAL CARE; META ANALYSIS (TOPIC); NEWBORN; NONHUMAN; PERINATAL INFECTION; POST EXPOSURE PROPHYLAXIS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); VACCINATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 84929078367     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piu064     Document Type: Article

References (40)

1. WHO. Hepatitis B. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed June 22, 2014.
2. WHO position paper on hepatitis B vaccines - October 2009. Wkly Epidemiol Rec 2009; 84:405-20.
3. Franco E, Bagnato B, Marino MG, et al. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol 2012; 4:74-80.
4. Smith EA, Jacques-Carroll L, Walker TY, et al. The national Perinatal Hepatitis B Prevention Program, 1994-2008; Pediatrics 2012; 129:609-16.
5. Jonas MM. Treatment of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr 2006; 43(Suppl 1):S56-60.
6. Cheung KW, Seto MT, Wong SF. Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2013; 169: 17-23.
7. Edmunds WJ, Medley GF, Nokes DJ, et al. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 1993; 253:197-201.
8. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA 1985; 253:1740-5.
9. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20:992-1000.
10. Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat 2012; 19:e18-25.
11. Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis 2012; 16:e82-8.
12. Poovorawan Y, Chongsrisawat V, Theamboonlers A, et al. Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand. Hum Vaccin Immunother 2013; 9:1679-84.
13. Margolis HS, Coleman PJ, Brown RE, et al. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 1995; 274:1201-8.
14. del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15:1624-30.
15. WenWH, ChangMH, Zhao LL, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013; 59:24-30.
16. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190:489-92.
17. Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011; 18:468-73.
18. Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012; 142:773-81e2.
19. Ni YH, Chang MH, Wu JF, et al. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 2012; 57:730-5.
20. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med 2007; 12:160-7.
21. Van Damme P, Ward J, Shouval D, Wiersma S, Zanetti A. Hepatitis B vaccines. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines. China: Saunders; 2012: pp 183-204.
22. Zhu YY, Mao YZ, Wu WL, et al. Does hepatitis B virus prenatal transmission result in postnatal immunoprophylaxis failure? Clin Vaccine Immunol 2010; 17:1836-41.
23. Song YM, Sung J, Yang S, et al. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007; 166:813-8.
24. Bai H, Zhang L, Ma L, et al. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterinetransmission mechanism. World J Gastroenterol 2007; 13: 3625-30.
25. Burk RD, Hwang LY, Ho GY, et al. Outcome of perinatal hepatitis-B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170:1418-23.
26. Han L, Zhang HW, Xie JX, et al. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011; 17:4321-33.
27. Okada K, Kamiyama I. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976; 294:746-9.
28. Giles ML, Visvanathan K, Lewin SR, Sasadeusz J. Chronic hepatitis B infection and pregnancy. Obstet Gynecol Surv, 2012; 67: 37-44.
29. Sun KX, Li J, Zhu FC, et al. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine 2012; 30:5335-40.
30. Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol, 2012; 10: 452-9.
31. del Canho R, Grosheide PM, Schalm SW, et al. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994; 20:483-6.
32. Bzowej NH. Optimal management of the hepatitis B patient who desires pregnancy or is pregnant. Curr Hepat Rep 2012; 11:82-9.
33. Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized doubleblind, placebo-controlled trial. Hepatology 1983; 3:135-41.
34. Hu XL, Zhou XP, Qian YL, et al. The presence and expression of the hepatitis B virus in human oocytes and embryos. Hum Reprod 2011; 26:1860-7.
35. Lutgens SP, Nelissen EC, van Loo IH, et al. To do or not to do: IVF and ICSI in chronic hepatitis B virus carriers. Hum Reprod 2009; 24:2676-8.
36. HadchouelM, Scotto J, Huret JL, et al. Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via the germ line. J Med Virol 1985; 16:61-6.
37. Nie R, Jin L, Zhang H, et al. Presence of hepatitis B virus in oocytes and embryos: a risk of hepatitis B virus transmission during in vitro fertilization. Fertil Steril 2011; 95:1667-71.
38. Ye F, Jin Y, Kong Y, et al. The presence of HBV mRNA in the fertilized in vitro embryo of HBV patients confirms vertical transmission of HBV via the ovum. Epidemiol Infect 2013; 141: 926-30.
39. Hieber JP, Dalton D, Shorey J, Combes B. Hepatitis and pregnancy. J Pediatr 1977; 91:545-9.
40. Practice Committee of American Society for Reproductive Medicine. Hepatitis and reproduction. Fertil Steril 2008; 90 (5 Suppl):S226-35.